Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review
- PMID: 36764582
- DOI: 10.1016/j.jaad.2023.01.034
Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review
Abstract
Background: The Ehlers-Danlos syndromes (EDSs) comprise a group of connective tissue disorders that manifest with skin hyperextensibility, easy bruising, joint hypermobility and fragility of skin, soft tissues, and some organs. A correct assessment of cutaneous features along with the use of adjunct technologies can improve diagnostic accuracy.
Objectives: To systematically review the cutaneous features and adjunct investigations of EDS.
Methods: A search of PubMed and Web of Science for EDS-related cutaneous features and additional investigations was undertaken from publication of the 2017 International Classification of EDS until January 15, 2022.
Results: One-hundred-and-forty studies involved 839 patients with EDS. The EDS female-to-male ratio was 1.36:1 (P < .001). A high prevalence of skin hyperextensibility, bruising, and soft skin were noted. Most patients with vascular Ehlers-Danlos syndrome showed venous visibility, skin fragility, and acrogeria. Classical EDS showed subcutaneous spheroids and molluscoid pseudotumours. In patients that underwent skin biopsies, only 30.3% and 71.4% showed features suggestive of EDS using light microscopy and transmission electron microscopy, respectively.
Limitations: Retrospective study and small cases numbers for some EDS-subtypes.
Conclusions: An accurate clinical diagnosis increases the chances of a molecular diagnosis, particularly for rarer EDS subtypes, whilst decreasing the need for genetic testing where there is a low clinical suspicion for a monogenic EDS-subtype.
Keywords: Ehlers-Danlos syndrome; heritable connective tissue disorders; joint hypermobility; skin fragility; skin hyperextensibility.
Copyright © 2023 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest None disclosed.
Similar articles
-
Diagnostic outcomes for molecular genetic testing in children with suspected Ehlers-Danlos syndrome.Am J Med Genet A. 2022 May;188(5):1376-1383. doi: 10.1002/ajmg.a.62672. Epub 2022 Feb 6. Am J Med Genet A. 2022. PMID: 35128800
-
Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.Orphanet J Rare Dis. 2020 Jul 31;15(1):197. doi: 10.1186/s13023-020-01470-0. Orphanet J Rare Dis. 2020. PMID: 32736638 Free PMC article.
-
The Ehlers-Danlos Syndromes against the Backdrop of Inborn Errors of Metabolism.Genes (Basel). 2022 Jan 29;13(2):265. doi: 10.3390/genes13020265. Genes (Basel). 2022. PMID: 35205310 Free PMC article. Review.
-
Electron microscopy in the diagnosis of Ehlers-Danlos syndromes: correlation with clinical and genetic investigations.Br J Dermatol. 2020 Mar;182(3):698-707. doi: 10.1111/bjd.18165. Epub 2019 Aug 21. Br J Dermatol. 2020. PMID: 31141158
-
Vascular aspects of the Ehlers-Danlos Syndromes.Matrix Biol. 2018 Oct;71-72:380-395. doi: 10.1016/j.matbio.2018.04.013. Epub 2018 Apr 27. Matrix Biol. 2018. PMID: 29709596 Review.
Cited by
-
Novel COL5A1 variants and associated disease phenotypes in dogs with classical Ehlers-Danlos syndrome.J Vet Intern Med. 2024 Sep-Oct;38(5):2431-2443. doi: 10.1111/jvim.17180. Epub 2024 Aug 22. J Vet Intern Med. 2024. PMID: 39175162 Free PMC article.
-
Health care supply in patients with Ehlers-Danlos syndromes and generalized hypermobility spectrum disorder: a German perspective.Orphanet J Rare Dis. 2025 Aug 16;20(1):436. doi: 10.1186/s13023-025-03937-4. Orphanet J Rare Dis. 2025. PMID: 40819036
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical